close Lefora Announcement: We recently turned back on the 'Send Invites' link in the userbar. New features include the ability to hook directly into your Hotmail, Yahoo, or Gmail accounts. Click here.

dottie32's Blog

Dottie M, Female, 32
Member For: 2 months, 2 weeks
Posts: 3

Member of: OTC Advisors Forum.
Top Post By dottie32 (most thumbs up):

No posts received thumbs up, next time you see a good one, give some respect and thumb it up.

Recent Posts by dottie32:

Re: Who Is Trading What????>?>?>?>?>?>?

October 7, 2008 by dottie32

Oh yea... GO OBAMA!

Who Is Trading What????>?>?>?>?>?>?

October 7, 2008 by dottie32

I'm long on AIG.

CEGE!!!!!!!!!!!!!!! I WOULD TAKE A LOOK INTO IT IF I WERE YOU

September 2, 2008 by dottie32

Cell Genesys (Nasdaq: CEGE) is focused on the development and commercialization of novel biological therapies for patients with cancer. The company's lead product platform is GVAX(R) immunotherapy for cancer, which holds the potential to treat multiple types of cancer including prostate cancer, leukemia, pancreatic cancer and lung cancer. Cell Genesys continues to hold an equity interest in its former subsidiary, Ceregene, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, California, and has manufacturing operations in Hayward, California. For additional information, please visit the company's website at www.cellgenesys.com.